386 results
Fast-acting therapies for suicidal ideation are needed. Find out whether ketamine might be useful in the latest EBM Focus article.
Recently, the members of the DynaMed® and IBM® Micromedex® with Watson™ team sat down with the Pharmacy Podcast Network to explore how artificial intelligence (AI) can help in areas such as clinical decision support.
Vaccination remains the most effective method to prevent severe outcomes of COVID-19, but what do we know about medications for pre-exposure and postexposure prophylaxis?
Every few months, another drug for potential use in treating dermatologic disorders seems to enter the pipeline. Patient choice is great, but unknown comparative efficacy, conflicts of interest, and prohibitive costs complicate this choice.
It’s not magic, but the magnitude of benefit for psilocybin compared to other available treatments for major depressive disorder plus its relative lack of adverse effects suggests that this treatment might be about ready for prime time.
A growing body of evidence obtained during the COVID-19 pandemic continues to point out the racial bias of pulse oximetry.
Penicillin is the most common drug allergy reported. However, most people are not actually allergic to penicillin. In this article, DynaMed Allergy Specialist Dr. Maureen Bauer answers common questions about penicillin allergy delabeling.
Oral phenylephrine, common in many OTC cold medicines, is no longer generally recognized as an effective nasal decongestant due to growing body of evidence.
Many Primary Care physicians manage veterans because most veterans do not seek healthcare from Veterans Affairs (VA) services. Hear from Army veteran and DynaMed Deputy Editor Dr. Dan Randall about considerations for the care of veterans.
EBSCO Nursing Consultant Kate ONeill, DNP, RN, explores the global diabetes epidemic, the pivotal role of health care professionals in diabetes management, the power of education and technology in raising awareness of this pervasive health challenge.